Larin Fe 1/20 Kit
Product Images NDC 16714-406

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Larin Fe 1/20 (NDC 16714-406). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 01)

Chemical structure diagram showing two compounds: Norethindrone Acetate on the left and Ethinyl Estradiol on the right. Both structures include detailed molecular representations with labeled functional groups corresponding to each hormone's composition.*

FDA Label Image

2 (Image 02)

Table showing lowest expected and typical failure rates during the first year of continuous contraceptive method use. It lists various methods such as no contraception, oral contraceptives, diaphragms, spermicides, vaginal sponge, implants, injections, IUDs, condoms, cervical caps, periodic abstinence, withdrawal, and sterilization, with corresponding percentages of women experiencing unintended pregnancy.*

FDA Label Image

3 (Image 03)

A text panel warning about the increased risk of serious cardiovascular side effects from oral contraceptive use associated with cigarette smoking. It notes the risk increases with age and heavy smoking (15 or more cigarettes per day), especially in women over 35 years old, advising that women using oral contraceptives should strongly avoid smoking.*

FDA Label Image

4 (Image 04)

A bar chart titled 'Circulatory Disease Mortality Rates Per 100,000 Woman Years by Age, Smoking Status and Oral Contraceptive Use.' The vertical axis shows mortality rate (number of deaths per 100,000 woman years) ranging from 0 to 250. The horizontal axis lists age groups: 15-24, 25-34, 35-44, and 45-. The chart compares mortality rates for four groups: ever-users (non-smokers), ever-users (smokers), controls (non-smokers), and controls (smokers), indicated by different shading patterns in the bars. Mortality rates increase with age and are highest among ever-users who smoke.*

FDA Label Image

5 (Image 05)

A data table titled 'Annual number of birth-related or method-related deaths associated with control of fertility per 100,000 nonsterile women by fertility control method according to age.' It categorizes death rates by fertility control methods (including no methods, oral contraceptives for smokers and non-smokers, IUD, condom, diaphragm/spermicide, periodic abstinence) across different age groups (15-19, 20-24, 25-29, 30-34, 35-39, and 40-44). Notes indicate some deaths are birth-related and some method-related.*

FDA Label Image

6 (Image 06)

A text panel warning that cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use, especially in women over 35 years old who smoke heavily. It advises women using oral contraceptives not to smoke.*

FDA Label Image

7 (Image 07)

Instructional diagram showing how to use the day label strip on the Larin Fe 1/20 oral contraceptive pill kit to align with the first day of the user's menstrual period. It illustrates placement of the label based on Sunday starters or Day-1 starters and indicates taking pills from left to right each week following the labeled days.*

FDA Label Image

8 (Image 08)

Text warning that cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use, especially in women over 35 and heavy smokers (15 or more cigarettes per day). Advises women using oral contraceptives not to smoke.*

FDA Label Image

9 (Image 09)

A warning statement panel that cautions women using oral contraceptives about increased risk of serious cardiovascular side effects associated with cigarette smoking. It highlights that risk increases with age and heavy smoking (15 or more cigarettes per day), and that women over 35 are strongly advised not to smoke while using oral contraceptives.*

FDA Label Image

10 (Image 10)

A data table presenting the annual number of birth-related or method-related deaths associated with control of fertility per 100,000 nonsterile women by fertility control method and age group. The table includes methods such as no fertility control, oral contraceptives (smoker and non-smoker), IUD, condom, diaphragm/spermicide, and periodic abstinence across age ranges 15-19 through 40-44.*

FDA Label Image

11 (Image 11)

An instructional diagram showing how to start taking Larin Fe 1/20 oral contraceptive pills. It illustrates a hand holding the pill strip, directing to start on Sunday or Day-1 based on the menstrual cycle, with arrows indicating to take the pills from left to right each week. The strip contains pills in three colors: pale yellow for inactive pills, brown for active pills, demonstrating the sequence of use.*

FDA Label Image

12 (Image 12)

FDA Label Image

13 (Image 13)

Packaging label for Larin Fe 1/20, a kit containing Norethindrone Acetate and Ethinyl Estradiol Tablets, USP, and Ferrous Fumarate Tablets, produced by Northstar Rx LLC. The label highlights 6 blister cards of 28 tablets each (total 168 tablets) with dosage and storage information. The NDC number 16714-406 is visible along with barcodes and manufacturer details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.